Menu
Home
Publishers
Categories
Trending
Inbox
Create Account
Sign in
Nederlands
Deutsch
Niaid.nih.gov
10241
Newsletters
0
Subscriptions
Subscribe
Click here to subscribe to Niaid.nih.gov
Newsletters
Register Today: Applying Cultural & Li nguistic Competency Standards to PASRR
Niaid.nih.gov
1 year ago
NIH awards will fund Post-Treatme nt Lyme Disease Syndrome research
Niaid.nih.gov
1 year ago
NIH Pain Consortium Symposium Videos Available
Niaid.nih.gov
1 year ago
HRSA eNews: July 2023, Volume 2
Niaid.nih.gov
1 year ago
Press Release: CMS Approves Californ ia & Kentucky Requests to Provide Ess ential Behavioral Health Services Thr ough Mobile Crisis Intervention Teams
Niaid.nih.gov
1 year ago
Omega-3 fatty acids appear promi sing for maintaining lung health
Niaid.nih.gov
1 year ago
New atlas of human kidney cells to help unlock kidney disease research
Niaid.nih.gov
1 year ago
Women treated for breast cancer ma y age faster than cancer-free women
Niaid.nih.gov
1 year ago
Traditional Chinese Medicine
Niaid.nih.gov
1 year ago
How to Find Help with SHOP Coverage
Niaid.nih.gov
1 year ago
Special Bulletin - HRSA June Roundup
Niaid.nih.gov
1 year ago
Join CMS for a Stakeholder Call on the Proposed Transit ional Coverage for Emerging Technologies (TCET) Pathway
Niaid.nih.gov
1 year ago
Understanding Causes of Devastating Neuro degenerative Condition Affecting Children
Niaid.nih.gov
1 year ago
Funding news for global health researchers: July 17, 2023
Niaid.nih.gov
1 year ago
CMS Coverage Email Updates
Niaid.nih.gov
1 year ago
Learn How Medications and Supplements Can Interact
Niaid.nih.gov
1 year ago
CMS Publishes Program Year 2022 Open Payments Data
Niaid.nih.gov
1 year ago
Safer Pregnancies | Hepatitis | T ooth Decay | Uveitis | Bone Health
Niaid.nih.gov
1 year ago
NCCIH Update: Have Student Loans? Apply f or NIH Loan Repayment through November 16
Niaid.nih.gov
1 year ago
Low-dose atropine eyedrops no better tha n placebo for slowing myopia progression
Niaid.nih.gov
1 year ago
Begin
Previous
58
59
60
61
62
63
64
65
66
67
Next
© 2024
Information
Terms and Conditions
Privacy
Close
Home
Publishers
Categories
Trending
Inbox
Create Account
Sign in
© 2024
Information
Terms and Conditions
Privacy
Nederlands
Deutsch